Copyright
©The Author(s) 2019.
World J Gastroenterol. Sep 14, 2019; 25(34): 5049-5068
Published online Sep 14, 2019. doi: 10.3748/wjg.v25.i34.5049
Published online Sep 14, 2019. doi: 10.3748/wjg.v25.i34.5049
Representative tumor-associated autoantigens | Authors, year | Tumor type | Biological significance |
p53 | Chapman et al[11], 2012 | Lung | Early detection |
Takeda et al[14], 2001 | Colorectal | Increased recurrence | |
Anderson et al[15], 2010 | Ovarian | Increased survival | |
NY-ESO-1 | Shan et al[16], 2013 | Lung | Early detection |
Fosså et al[17], 2004 | Prostate | Decreased survival | |
Elke et al[18], 1999 | Melanoma | Therapeutic monitoring | |
MUC1 | Pedersen et al[19], 2014 | Ovarian | Early detection |
Kurtenkov et al[20], 2007 | Gastric | Increased survival | |
Hu | Chapman et al[11], 2011 | Lung | Early detection |
Graus et al[21], 1997 | Lung | Therapeutic monitoring and increased survival |
- Citation: Xu YW, Peng YH, Xu LY, Xie JJ, Li EM. Autoantibodies: Potential clinical applications in early detection of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma. World J Gastroenterol 2019; 25(34): 5049-5068
- URL: https://www.wjgnet.com/1007-9327/full/v25/i34/5049.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i34.5049